Hologic (HOLX) Tops Q2 EPS by 5c; offers guidance

Hologic (NASDAQ: HOLX) reported Q2 EPS of $1.03, $0.05 better than the analyst estimate of $0.98. Revenue for the quarter came in at $0 versus the consensus estimate of $1.02 billion.

GUIDANCE:

Hologic sees FY2024 EPS of $4.02-$4.12, versus the consensus of $4.03. Hologic sees FY2024 revenue of $4-4.05 billion, versus the consensus of $4.03 billion.

Hologic sees Q3 2024 EPS of $0.98-$1.05, versus the consensus of $1.02. Hologic sees Q3 2024 revenue of $992.5-1.0075 billion, versus the consensus of $1.01 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Micron Technology (MU) PT Raised to $1,280 at Baird
• Barclays Downgrades Brown Forman (BF-B) to Equalweight